Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a serious adverse event of bone resorption inhibitors (BRIs), such as zoledronic acid and denosumab. Based on the results of phase 3 clinical trials for BRIs, the frequency of ARONJ is 1 to 2%, but the actual frequency is presumed to b...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 68(2022), 1 vom: 02. Jan., Seite 1-6
|
|---|
| 1. Verfasser: |
Kawanishi, Hiroaki
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Yokozeki, Hitoshi,
Hoshiyama, Akihiro,
Watanabe, Hiroki,
Funahashi, Yurina,
Fujiwara, Maki,
Takashima, Yasushi,
Shintani, Motoko,
Yui, Shumpei,
Okumura, Kazuhiro |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2022
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | Journal Article
Bone Density Conservation Agents |
|---|